Stephanie Klosterhalfen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stephanie Klosterhalfen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Kotz
Institut für Allgemeinmedizin (ifam), Schwerpunkt Suchtforschung und klinische Epidemiologie, Centre for Health and Society (chs), Medizinische Fakultät und Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Deutschland
2 shared publications - Anne Starker
Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany
1 shared publication - Benjamin Kuntz
Robert Koch Institute, Berlin, Department of Epidemiology and Health Monitoring
1 shared publication - Christian Funke
Institute of General Practice, Heinrich Heine University Düsseldorf (Institut für Allgemeinmedizin, Heinrich-Heine-Universität Düsseldorf), Düsseldorf, Germany
1 shared publication Daniel Kotz
Heinrich-Heine-Universität Düsseldorf Medizinische Fakultät: Heinrich-Heine-Universitat Dusseldorf Medizinische Fakultat
1 shared publication- Diana Lubisch
Heinrich-Heine-University Duesseldorf, Institute of General Practice, Addiction Research and Clinical Epidemiology Unit, Duesseldorf, Germany
1 shared publication
Latest Publications
- Open Access
- 12 May 2021
- Published by Springer Nature in Research Square
Did self‐reported tobacco smoking, alcohol consumption, and physical activity change during the COVID-19 restrictions in Germany in spring 2020? Findings from a population survey (the DEBRA study)
Background Broad nationwide restrictions of social life and contacts were implemented in Germany on March 22nd, 2020, to reduce the spread of the severe acute respiratory syndrome coronavirus type 2 (SARS‑CoV‑2). It is unclear how these restrictions affected peoples’ health behaviour. Objective To: i) examine changes in self-reported health behaviour of the German population regarding tobacco smoking, alcohol consumption, and physical activity during the restrictions compared with the time prior to these restrictions; ii) explore associations between potential changes and socioeconomic and sociodemographic characteristics. Methods We used data from two waves (June-August 2020) of the German Study on Tobacco Use (DEBRA): a cross-sectional, representative, face-to‐face household survey in people aged ≥ 14 years (N = 4078). Associations between socioeconomic and sociodemographic characteristics and changes in each health behaviour were analysed using multinomial logistic regression analyses (categories of the dependent variable: increase, no change, decrease). Results People reported changes in their health behaviour: smoking increase = 24.0% (95% confidence interval (CI) = 21.5–26.7), decrease = 12.2% (95%CI = 10.4–14.4); alcohol consumption increase = 12.9% (95%CI = 11.7–14.1), decrease = 19.9% (95%CI = 18.4–21.3); physical activity increase = 18.5% (95%CI = 17.3–19.7); decrease = 29.4% (95%CI = 28.0–31.0). People with a lower level of education and younger age were more likely to report a harmful change in health behaviour. Conclusion The majority of people in Germany did not change their health behaviour during the 2020 corona restrictions. Among those who changed, relatively more increased their smoking and decreased their alcohol consumption and physical activity. Public health interventions in this context should particularly target people with lower socioeconomic status and younger age e.g., by offering more online courses.
- 12 May 2021
- Published by Springer Nature in Research Square
Open AccessDid self‐reported tobacco smoking, alcohol consumption, and physical activity change during the COVID-19 restrictions in Germany in spring 2020? Findings from a population survey (the DEBRA study)
Background Broad nationwide restrictions of social life and contacts were implemented in Germany on March 22nd, 2020, to reduce the spread of the severe acute respiratory syndrome coronavirus type 2 (SARS‑CoV‑2). It is unclear how these restrictions affected peoples’ health behaviour. Objective To: i) examine changes in self-reported health behaviour of the German population regarding tobacco smoking, alcohol consumption, and physical activity during the restrictions compared with the time prior to these restrictions; ii) explore associations between potential changes and socioeconomic and sociodemographic characteristics. Methods We used data from two waves (June-August 2020) of the German Study on Tobacco Use (DEBRA): a cross-sectional, representative, face-to‐face household survey in people aged ≥ 14 years (N = 4078). Associations between socioeconomic and sociodemographic characteristics and changes in each health behaviour were analysed using multinomial logistic regression analyses (categories of the dependent variable: increase, no change, decrease). Results People reported changes in their health behaviour: smoking increase = 24.0% (95% confidence interval (CI) = 21.5–26.7), decrease = 12.2% (95%CI = 10.4–14.4); alcohol consumption increase = 12.9% (95%CI = 11.7–14.1), decrease = 19.9% (95%CI = 18.4–21.3); physical activity increase = 18.5% (95%CI = 17.3–19.7); decrease = 29.4% (95%CI = 28.0–31.0). People with a lower level of education and younger age were more likely to report a harmful change in health behaviour. Conclusion The majority of people in Germany did not change their health behaviour during the 2020 corona restrictions. Among those who changed, relatively more increased their smoking and decreased their alcohol consumption and physical activity. Public health interventions in this context should particularly target people with lower socioeconomic status and younger age e.g., by offering more online courses.
- Open Access
- 22 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 7740
Waterpipe Use among Adolescents in Germany: Prevalence, Associated Consumer Characteristics, and Trends (German Health Interview and Examination Survey for Children and Adolescents, KiGGS)
Waterpipe (WP) use is popular among youth worldwide, but epidemiological data from Germany are scarce. We aimed to describe prevalence rates of WP use (current, last 12 months, ever) and analysed correlates and trends among 11- to 17-year-olds in Germany. Analyses were based on data from the “German Health Interview and Examination Survey for Children and Adolescents” study during 2014–2017 (n = 6599). Changes in WP use prevalence compared with 2009–2012 were used to describe trends. Associations with sociodemographic characteristics and cigarette smoking were assessed with multivariable logistic regression models. Prevalence of current WP use among adolescents was 8.5% (95% confidence interval (CI) = 7.5–9.6), use in the last 12 months was 19.7% (95% CI = 18.3–21.2), and ever use was 25.8% (95% CI = 24.2–27.5). High prevalence rates were particularly found among 16–17-year-olds. During 2009–2012, these prevalence rates were 9.0%, 18.5%, and 26.1%, respectively. WP use was associated with older age, male sex, migration background, lower educational level, and current smoking status. Among current WP users, 66.2% (95% CI = 60.0–71.9) identified themselves as non-smokers, and 38.1% (95% CI = 32.5–44.0) had used WP ≥ three times in the last month. WP consumption is popular among German youth, and prevalence rates have not changed over time. Specific prevention strategies to reduce harmful WP consumption among youth should be implemented.
- 22 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 7740
Open AccessWaterpipe Use among Adolescents in Germany: Prevalence, Associated Consumer Characteristics, and Trends (German Health Interview and Examination Survey for Children and Adolescents, KiGGS)
Waterpipe (WP) use is popular among youth worldwide, but epidemiological data from Germany are scarce. We aimed to describe prevalence rates of WP use (current, last 12 months, ever) and analysed correlates and trends among 11- to 17-year-olds in Germany. Analyses were based on data from the “German Health Interview and Examination Survey for Children and Adolescents” study during 2014–2017 (n = 6599). Changes in WP use prevalence compared with 2009–2012 were used to describe trends. Associations with sociodemographic characteristics and cigarette smoking were assessed with multivariable logistic regression models. Prevalence of current WP use among adolescents was 8.5% (95% confidence interval (CI) = 7.5–9.6), use in the last 12 months was 19.7% (95% CI = 18.3–21.2), and ever use was 25.8% (95% CI = 24.2–27.5). High prevalence rates were particularly found among 16–17-year-olds. During 2009–2012, these prevalence rates were 9.0%, 18.5%, and 26.1%, respectively. WP use was associated with older age, male sex, migration background, lower educational level, and current smoking status. Among current WP users, 66.2% (95% CI = 60.0–71.9) identified themselves as non-smokers, and 38.1% (95% CI = 32.5–44.0) had used WP ≥ three times in the last month. WP consumption is popular among German youth, and prevalence rates have not changed over time. Specific prevention strategies to reduce harmful WP consumption among youth should be implemented.
- Open Access
Effectiveness of training general practitioners in the ABC versus 5As method of delivering brief stop-smoking advice: a pragmatic, two-arm cluster randomised controlled trial
OBJECTIVE: To assess the effectiveness of a 3.5h-training for general practitioners (GPs) in two different methods (ABC, 5As) of giving brief stop-smoking advice during routine consultations. DESIGN: Pragmatic two-arm cluster randomised controlled trial with pre-post-design for the primary outcome and cluster randomisation for secondary outcomes. SETTING: General practices, North Rhine-Westphalia (German federal state), recruited 2017-2019. PARTICIPANTS: Practices were randomised (1:1) to an ABC or 5As training. Tobacco smoking, adult patients, who consulted trained GPs in these practices in the 6 weeks prior to or following the training were eligible to participate. Ineligible were: non-smokers, patients who did not meet the GP in person, or could not provide informed consent. INTERVENTIONS: Two different standardised 3.5h-trainings (ABC or 5As) for GPs in delivering brief stop-smoking advice were carried out per study cycle (six cycles in total). Trainings were moderated by a senior researcher and an experienced GP, and included role-plays with professional actors. MAIN OUTCOME MEASURES: Primary outcome: patient-reported rates of GP-delivered stop-smoking advice prior and following the training, irrespective of the training method. Secondary outcomes: patient-reported receipt of recommendation/prescription of evidence-based smoking cessation treatment: including behavioural support, any pharmacotherapy (nicotine replacement therapy (NRT), varenicline, or bupropion), or a combination therapy; and the effectiveness of ABC versus 5As regarding all outcomes. RANDOMISATION AND MASKING: Computer-generated block randomisation or, if not feasible, randomisation based on the GPs’ temporal availability at training dates. GPs were not fully blinded. Patients were blinded to the nature of the study until data collection ended. RESULTS: 52 GP practices (27 ABC, 25 5As) with 69 GPs were included. Of 5,406 patients who provided informed consent, 1,937 (35.9%) were current smokers, of whom 1,039 were interviewed prior to and 898 following the training. GP-delivered stop-smoking advice increased from 13.1% (n=136/1,039) to 33.1% (n=297/898) following the training (adjusted odds ratio (aOR)=3.25, 95%CI=2.34 to 4.51). Recommendation/prescription rates of treatment were low (<2%) pre-training, but had increased after the training (e.g., behavioural support: aOR=7.15, 95%CI=4.02 to 12.74; any pharmacotherapy: aOR=7.99, 95%CI=4.11 to 15.52). GP-delivered stop-smoking advice increased non-significantly (p=0.08) stronger in the ABC vs. 5As group (aOR=1.71, 95%CI=0.94 to 3.12). CONCLUSIONS: In GPs in Germany, a single session of training in stop-smoking advice was associated with a three-fold increase in rates of advice giving and a seven-fold increase in offer of support. The ABC method may lead to higher rates of GP-delivered stop-smoking advice during routine consultations. Approaches to further increase the delivery of such advice, and upscaling implementation strategies for the training in general practice, should be evaluated. TRIAL REGISTRATION: German Clinical Trials Register: DRKS00012786. WHAT IS ALREADY KNOWN ON THIS TOPIC: The implementation of clinical guideline recommendations stating that general practitioners (GPs) should routinely deliver brief stop-smoking advice and offer evidence-based smoking cessation treatment is low in Germany, a country with a smoking prevalence of ∼28%. A strategy is needed to overcome barriers (e.g., lack in knowledge and skills) preventing GPs from routinely delivering stop-smoking advice. No experimental study has evaluated such a strategy in German general practice so far. Two different methods of delivering such advice are recommended in the national guidelines – ABC and 5As – but it is unclear which method can be more effectively implemented by trained GPs. WHAT THIS STUDY ADDS: This cluster randomised controlled trial evaluated the effectiveness of a 3.5h-training for GPs in delivering brief stop-smoking advice and compared two different methods (ABC vs. 5As) regarding the rates of delivery of such advice and recommendations of evidence-based cessation treatment in 1,937 smoking patients from 52 GP practices in Germany. The training, irrespective of the method, was associated with a three-fold increase in rates of advice giving and a seven-fold increase in the offer of support. The data indicate that training according to ABC may be more effective than 5As in increasing the rates of GP-delivered stop-smoking advice.
Open AccessEffectiveness of training general practitioners in the ABC versus 5As method of delivering brief stop-smoking advice: a pragmatic, two-arm cluster randomised controlled trial
OBJECTIVE: To assess the effectiveness of a 3.5h-training for general practitioners (GPs) in two different methods (ABC, 5As) of giving brief stop-smoking advice during routine consultations. DESIGN: Pragmatic two-arm cluster randomised controlled trial with pre-post-design for the primary outcome and cluster randomisation for secondary outcomes. SETTING: General practices, North Rhine-Westphalia (German federal state), recruited 2017-2019. PARTICIPANTS: Practices were randomised (1:1) to an ABC or 5As training. Tobacco smoking, adult patients, who consulted trained GPs in these practices in the 6 weeks prior to or following the training were eligible to participate. Ineligible were: non-smokers, patients who did not meet the GP in person, or could not provide informed consent. INTERVENTIONS: Two different standardised 3.5h-trainings (ABC or 5As) for GPs in delivering brief stop-smoking advice were carried out per study cycle (six cycles in total). Trainings were moderated by a senior researcher and an experienced GP, and included role-plays with professional actors. MAIN OUTCOME MEASURES: Primary outcome: patient-reported rates of GP-delivered stop-smoking advice prior and following the training, irrespective of the training method. Secondary outcomes: patient-reported receipt of recommendation/prescription of evidence-based smoking cessation treatment: including behavioural support, any pharmacotherapy (nicotine replacement therapy (NRT), varenicline, or bupropion), or a combination therapy; and the effectiveness of ABC versus 5As regarding all outcomes. RANDOMISATION AND MASKING: Computer-generated block randomisation or, if not feasible, randomisation based on the GPs’ temporal availability at training dates. GPs were not fully blinded. Patients were blinded to the nature of the study until data collection ended. RESULTS: 52 GP practices (27 ABC, 25 5As) with 69 GPs were included. Of 5,406 patients who provided informed consent, 1,937 (35.9%) were current smokers, of whom 1,039 were interviewed prior to and 898 following the training. GP-delivered stop-smoking advice increased from 13.1% (n=136/1,039) to 33.1% (n=297/898) following the training (adjusted odds ratio (aOR)=3.25, 95%CI=2.34 to 4.51). Recommendation/prescription rates of treatment were low (<2%) pre-training, but had increased after the training (e.g., behavioural support: aOR=7.15, 95%CI=4.02 to 12.74; any pharmacotherapy: aOR=7.99, 95%CI=4.11 to 15.52). GP-delivered stop-smoking advice increased non-significantly (p=0.08) stronger in the ABC vs. 5As group (aOR=1.71, 95%CI=0.94 to 3.12). CONCLUSIONS: In GPs in Germany, a single session of training in stop-smoking advice was associated with a three-fold increase in rates of advice giving and a seven-fold increase in offer of support. The ABC method may lead to higher rates of GP-delivered stop-smoking advice during routine consultations. Approaches to further increase the delivery of such advice, and upscaling implementation strategies for the training in general practice, should be evaluated. TRIAL REGISTRATION: German Clinical Trials Register: DRKS00012786. WHAT IS ALREADY KNOWN ON THIS TOPIC: The implementation of clinical guideline recommendations stating that general practitioners (GPs) should routinely deliver brief stop-smoking advice and offer evidence-based smoking cessation treatment is low in Germany, a country with a smoking prevalence of ∼28%. A strategy is needed to overcome barriers (e.g., lack in knowledge and skills) preventing GPs from routinely delivering stop-smoking advice. No experimental study has evaluated such a strategy in German general practice so far. Two different methods of delivering such advice are recommended in the national guidelines – ABC and 5As – but it is unclear which method can be more effectively implemented by trained GPs. WHAT THIS STUDY ADDS: This cluster randomised controlled trial evaluated the effectiveness of a 3.5h-training for GPs in delivering brief stop-smoking advice and compared two different methods (ABC vs. 5As) regarding the rates of delivery of such advice and recommendations of evidence-based cessation treatment in 1,937 smoking patients from 52 GP practices in Germany. The training, irrespective of the method, was associated with a three-fold increase in rates of advice giving and a seven-fold increase in the offer of support. The data indicate that training according to ABC may be more effective than 5As in increasing the rates of GP-delivered stop-smoking advice.